Dosimetry of rhenium-188 diethylene triamine penta-acetic acid for endovascular intra-balloon brachytherapy after coronary angioplasty

European Journal of Nuclear Medicine

Volumn 27, Issue 1, 2000, Pages 76-82

  Lee, Jin ^a   Lee, Dong Soo ^a,b   Kim, Kyeong Min ^a   Yeo, Jeong Seok ^a   Cheon, Gi Jeong ^a   Kim, Seok Ki ^a   Ahn, Ji Young ^a   Jeong, Jae Min ^a   Chung, June Key ^a   Lee, Myung Chul ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Dosimetry; Endovascular brachytherapy; MIRD; Prevention of restenosis; Rhenium 188 diethylene triamine penta acetic acid

Indexed keywords

PENTETIC ACID; RHENIUM 188;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BALLOON; BLOOD VESSEL WALL; BRACHYTHERAPY; COMPUTER PROGRAM; CONTROLLED STUDY; DOG; DOSIMETRY; FILM DOSIMETER; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHANTOM; RADIATION DOSE DISTRIBUTION; RADIATION EXPOSURE; RESTENOSIS; SYSTEM ANALYSIS;

EID: 0033954538     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00006667     Document Type: Article

References (27)

1. 1. King SB III. The development of interventional cardiology. J Am Coll Cardiol 1998; 31: 264-284.
2. 2. Waksman R, Serruys PW. Handbook of vascular brachytherapy. London: Martin Dunitz, 1998.
3. 3. Condado JA, Waksman R, Gurdiel O, et al. Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans. Circulation 1997; 96: 727-732.
4. 4. Verin V, Urban P, Popwski Y, et al. Feasibility of intracoronary β-irradiation to reduce restenosis after balloon angioplasty. Circulation 1997; 95: 1138-1144.
5. 5. Carter AJ, Laird JR, Bailey LR, et al. Effects of endovascular radiation from a β-particle-emitting stent in a porcine coronary restenosis model. Circulation 1996; 94: 2364-2368.
6. 6. Lansky AJ, Popma JJ, Columbo A, et al. Follow-up angiographic comparison of the low dose vs. high dose phosphorous-32 radioactive isostent. Results from expanded IRIS and Milan dose A studies [abstract]. J Am Coll Cardiol 1999; 33: 17A.
7. 7. Knapp FF Jr, Guhlke S, Beets AL, Amols H, Weinberger J. Rhenium-188 attractive properties for intravascular brachytherapy for inhibition of coronary artery restenosis after PTCA [abstract]. J Nucl Cardiol 1997; 4: S118.
8. 8. Weinberger J, Amols HI, Schiff PB, et al. Initial results of the CURE safety trial: coronary brachytherapy with radioactive-liquid-filled balloons [abstract]. J Am Coll Cardiol 1999; 33: 94A.
9. 9. Giedd KN, Amols H, Marbos C, Knapp FF Jr, Weinberger J. Effectiveness of a beta-emitting liquid-filled balloon to prevent restenosis [abstract]. Circulation 1997; 96: I-220.
10. 10. Knapp FF Jr, Callahan AP, Beets AL, Mirzadeh S, Hsieh BT. Processing of reactor-produced W-188 for fabrication of clinical scale alumina-based W-188/Re-188 generators. Appl Radiat Isot 1994; 12: 1123-1128.
11. 11. Guhlke S, Beets AL, Biersack HJ, Knapp FF Jr. Elution of Re-188 from W-188/Re-188 generators with salts of weak acids permits efficient concentration to low volumes using a new tandem cation/anion exchange system [abstract]. J Nucl Med 1997; 38; 125.
12. 12. Lee J, Lee DS, Kim YJ, et al. Labeling and biodistribution of Re-188-DTPA. Korean J Nucl Med 1997; 31: 427-432.
13. 13. Scott NA, Cipolla GD, Ross CE, et al. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 1996; 93: 2178-2187.
14. 14. Teirstein P. β-radiation to reduce restenosis. Too little, too soon? Circulation 1997; 95: 1095-1097.
15. 15. Prestwich WV, Kennett TJ. The dose distribution produced by P-32 coated stent Med Phys 1995; 22: 313-320.
16. 16. Loevinger R, Berman M. A schema for absorbed dose calculations for biologically distributed radionuclides (MIRD Pamphlet No. 1). J Nucl Med 1968; 9 Suppl 1: 7-14.
17. 17. Berger MJ. Distribution of absorbed dose around point sources of electrons and beta particles in water and other media (MIRD Pamphlet No. 7). J Nucl Med 1971; 12 Suppl 5; 5-24.
18. 18. Nelson WR, Hirayama H, Rogers D. The EGS4 Code System. SLAC Report 265; 1985.
19. 19. Joh CW, Kang HJ, Park CH, et al. Absorbed dose distribution of Ho-166 endovascular irradiation using balloon angio catheter [abstract]. J Nucl Med 1998; 39; 85P.
20. 20. Michael GS. MIRDOSE: Personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 1996; 37: 538-546.
21. 21. Thomas SR, Atkins HL, McAfee JG, et al. MIRD dose estimate report No. 12 Radiation absorbed dose from Tc-99m DTPA. J Nucl Med 1984; 25: 503-505.
22. 22. Serruys PW, Levenberg PC. Intracoronary brachytheray: the death knell of restenosis or just another episode of a never-ending story? Circulation 1997; 96: 709-712.
23. 23. Waksman R, Chan RC, Soares C, Abizaid A, Mintz GS. The importance of centering for intracoronary radiation therapy in stented arteries. An ultrasound-dosimetry analysis of 4 commercial systems utilizing γ and β emitters [abstract]. J Am Coll Cardiol 1999; 33: 17A.
24. 24. Kim H-S, Cho Y-H, Kim J-S, et al. Effect of transcatheter endovascular holmium-166 irradiation on neointimal formation after balloon injury in porcine coronary artery [abstract]. J Am Coll Cardiol 1998; 31: 277A.
25. 25. Waksman R, Rodriguez JC, Robinson KA, Cipolla GD, Crocker IR, Scott NA. Effect of intravascular irradiation on cell proliferation, apoptosis, and vascular remodeling after balloon overstretch injury of porcine coronary arteries. Circulation 1997; 96: 1944-1952.
26. 26. Crilly RJ, Roberts, Spears JR. Perturbation irradiation fields due to calcification for isotopes considered for intravascular brachytherapy [abstract]. Circulation 1997; 96: 115.
27. 27. YJ Choi, KH Yoo, Chae IH, et al. Mechanism of radiation effect of endovascular Re-188 brachytherapy on restenosis of vessels after angioplasty [abstract]. Korean Circ J 1998; 28: II-307.